Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2017
Pharma News, 2017
Teva announces generic Reyataz capsules
Teva has introduced its generic of Reyataz (atazanavir) capsules within the United States, the company announced.
Dr.Reddy’s launches Melphalan Hydrochloride for injection
Dr.
Martin Shkreli’s former lawyer was convicted by a federal jury of conspiring with his ex-client to defraud investors
Martin Shkreli’s former lawyer was convicted by a federal jury of conspiring with his ex-client to defraud investors on Wednesday.
Mitochondrial metabolite linked to regulation of neurotransmission
A team of researchers has discovered a novel level of regulation of the communication between neurons and other cells.
Vitamin D, calcium supplements may not lower fracture risk
(Reuters Health) - Older adults who take vitamin D and calcium are no less likely to break their hips or other bones than peers who don’t use these supplements, a research review suggests.
Mallinckrodt to buy Sucampo for about $840 million
(Reuters) - Mallinckrodt Plc (MNK.
ICER’s report on VMAT2 inhibitors for tardive dyskinesia says they are ‘vastly overpriced’
The US Institute for Clinical and Economic Review (ICER) has released a Final Evidence Report and Report-at-a-Glance on vesicular monoamine transporter 2 (VMAT2) inhibitors for managem...
Theranos Secures $100 Million in New Funding from Fortress Capital
Theranos, the digraced medical-technology startup that infamously inflated the capabilities of its devices, has secured $100 million in new funding in the form of a loan.
EU Follows US and Approves Chugai's ALK Inhibitor "Alecensa®" as First Line Therapy for ALK-Positive Non-Small Cell Lung Cancer
TOKYO--(BUSINESS WIRE)--Chugai Pharmaceutical Co.
Walmart, CVS Health execs to address NRF 2018 convention
Executives from Walmart and CVS Health will be among the biggest names addressing the National Retail Federation’s 107th annual convention in mid-January 2018.
FDA Approves Luxturna (voretigene neparvovec-rzyl) Gene Therapy to Treat Patients with a Rare Form of Inherited Vision Loss
December 20, 2017 -- The U.
Israel's Super-Pharm in talks to buy Teva Pharm plant: source
TEL AVIV (Reuters) - Israel’s largest pharmacy chain Super-Pharm (Israel) Ltd is in talks to acquire Teva Pharmaceutical Industries’ plant in the coastal city of Ashdod, a source f...
1
2
3
4
5
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds